Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT

Clinical trial NCT02728700 · TERMINATED

Trial details

NCT number: NCT02728700
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Hodgkin Lymphoma Adult Myelodysplastic Syndrome Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Hodgkin Lymphoma Childhood Myelodysplastic Syndrome Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelofibrosis Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Non-Hodgkin Lymphoma

Start date: 2016-02-01
Primary completion: 2017-04-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.